$NLY, $FISV, $KEY, $MBIO, $PSX, $SRPT
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Monday follows:
Annaly Capital Management Inc. (NYSE:NLY) was started with a Buy rating at UBS with a 9.50 target. That compares to the consensus target on Wall Street of 10.10.
Fiserv Inc. (NASDAQ:FISV) was started with a Buy rating at Raymond James with a 103 price objective. That compares with the Wall Street consensus which is set at 98.65.
KeyCorp (NYSE:KEY) is raised to Outperform from Neutral at Baird.
Mustang Bio Inc. (NASDAQ:MBIO) was started with a Buy rating at Cantor Fitz with a 7 target. That compares with a consensus target at 19.50.
Phillips 66 (NYSE:PSX) is raised to Buy from Neutral at Citigroup. The consensus price target for the company is posted at 116.87.
Sarepta Therapeutics Inc (NASDAQ:SRPT) is being called among the Top picks at Merrill Lynch for the rest of Y 2019. The biotech has traded between 95.21 and 165.87 over the last year. Shares last seen at 129.79 Friday.
Have a terrific week
Latest posts by Paul Ebeling (see all)
- Stock Traders Bet Fed Will Cut Rates - October 20, 2019
- Mexico Is Paying for President Trump’s Wall (in Part) - October 20, 2019
- The 5 Safest Cities in the World - October 13, 2019